Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Serine/threonine-protein kinase B-raf | ||
Ligand | BDBM50026206 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_685663 (CHEMBL1285565) | ||
IC50 | <0.320000±n/a nM | ||
Citation | Wang, X; Berger, DM; Salaski, EJ; Torres, N; Dutia, M; Hanna, C; Hu, Y; Levin, JI; Powell, D; Wojciechowicz, D; Collins, K; Frommer, E; Lucas, J Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity. J Med Chem53:7874-8 (2010) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Serine/threonine-protein kinase B-raf | |||
Name: | Serine/threonine-protein kinase B-raf | ||
Synonyms: | B-RAF | B-Raf Protein Kinase | B-Raf proto-oncogene serine/threonine-protein kinase | BRAF | BRAF1 | BRAF_HUMAN | RAFB1 | p94 | v-Raf murine sarcoma viral oncogene homolog B1 | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 84446.00 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P15056 | ||
Residue: | 766 | ||
Sequence: |
| ||
BDBM50026206 | |||
n/a | |||
Name | BDBM50026206 | ||
Synonyms: | CHEMBL1276195 | ||
Type | Small organic molecule | ||
Emp. Form. | C33H30F2N8 | ||
Mol. Mass. | 576.6417 | ||
SMILES | [H][C@]12CN(c3cc(F)c(c(F)c3)-c3ccnc4c(c(nn34)-c3ccncc3)-c3cccc4[nH]ncc34)[C@]([H])(CN1CC(C)C)C2 |r,wU:36.42,1.0,(21.41,.41,;20.33,-.69,;20.34,-2.23,;19,-3.01,;19.01,-4.54,;17.67,-5.32,;17.69,-6.86,;16.35,-7.64,;19.02,-7.62,;20.35,-6.85,;21.69,-7.62,;20.35,-5.31,;19.03,-9.16,;17.7,-9.93,;17.7,-11.48,;19.03,-12.25,;20.37,-11.47,;21.84,-11.95,;22.75,-10.7,;21.84,-9.44,;20.36,-9.92,;24.29,-10.69,;25.06,-12.03,;26.6,-12.03,;27.37,-10.7,;26.59,-9.36,;25.06,-9.36,;22.32,-13.42,;23.82,-13.73,;24.3,-15.19,;23.27,-16.35,;21.76,-16.03,;20.51,-16.92,;19.27,-16.01,;19.75,-14.56,;21.29,-14.56,;17.67,-2.25,;16.12,-2.25,;17.66,-.71,;18.99,.07,;18.98,1.62,;20.31,2.39,;20.31,3.93,;21.65,1.63,;18.75,-1.15,)| | ||
Structure |